TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
IRD

Opus Genetics, Inc.

Healthcare · Biotechnology

5.10$ +6.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IRD
Line item 2019 2020 2021 2022 2023 2024 2025
– +891.1% +47.5% +87.9% +10.1% -31.7% +36.3%
– +902.7% +47.5% +87.9% +10.1% -32.1% +36.7%
– +966.9% +49.6% +73.8% +18.5% -40.0% +48.7%
– +966.9% +50.9% +72.4% +18.4% -40.0% +48.7%
– – – – -51.9% +147.4% -45.2%
– +233.4% -87.6% -28.6% +46.8% +645.6% +15.8%
– -65.9% +21.0% -28.6% +46.8% +179.4% -31.1%
– – – – – – –
– +255.0% +30.5% -32.5% +101.4% +46.2% +4.6%
– – – – – – –
– – – +108.1% +7.9% -86.5% +128.3%
– – – – – – –
– -34.3% +218.7% +38.7% +4.8% +23.7% +2,229.1%

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?